Journal ArticleOPEN ACCESS

Are Biopharma Firms Discontinuing Doomed Drug Discovery Projects Fast Enough?

Production and Operations Management (2022) 31(4) 1454-1455
DOI: 10.1111/poms.13621
2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Annapoornima M. Subramanian, Moren Lévesque, and Vareska Van De Vrande were recognized as a runner up for the 2020 Ralph Gomory Best Industry Studies Paper Award.

Author supplied keywords

Cite

CITATION STYLE

APA

Subramanian, A. M., Lévesque, M., & Van De Vrande, V. (2022). Are Biopharma Firms Discontinuing Doomed Drug Discovery Projects Fast Enough? Production and Operations Management, 31(4), 1454–1455. https://doi.org/10.1111/poms.13621

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free